An overview of the worldwide master key for pharmacovigilance and its role in India

Introduction: Pharmacovigilance (PV) is defined as the science and activities related to detection, assessment, understanding, prevention of Adverse Drug Reactions (ADRs) conditions.
 Methods: In 1970s, several significant cases ADR aided advancement discipline. Between 1989 2004, attempts were made implement such a program in India, but scheme was eventually launched 2010 now operating successfully producing positive results.
 Results: The pharmacovigilance Program India (PvPI) contributed different data World Health Organization (WHO) Uppsala Monitoring Center (UMC) based on gathered from this process. Indian regulatory have sent alerts stakeholders provided Central Drugs Standard Control (CDSCO) with recommendations. CDSCO has since advised Marketing Authorisation Holders (MAHs) follow same guidelines amended Cosmetics Act Regulations reflect this.
 Conclusions: time come for authorities take required action generated our country rather than other countries.